Launching Soon

    AI-Powered Platform for Biotech Evaluation, Growth and Investment

    Integrating industry insights with AI to streamline fundraising, automate pipeline priorization and positioning , and strengthen investor engagement

    >$1Trillion
    Market Size
    Global biotech market by 2030
    40+
    Expertise
    Years combined industry experience
    10M+
    Knowledge Base
    Biotech data points analyzed
    Platform Core

    Four pillars of biotech excellence

    Valuation & Risk

    AI-powered valuation and risk analysis

    Smart Data Rooms

    Real-time analysis and insights

    Auto Reports

    Market and competitive analysis

    Project Management

    Milestone and regulatory tracking

    Powered by Industry-Trained AI

    Domain expertise meets artificial intelligence

    Our AI models combine decades of biotech expertise with cutting-edge technology. Trained on industry-specific data and enriched with knowledge from senior domain experts to deliver actionable insights for founders and investors.

    FOR FOUNDERS
    INTELLIGENT VALUATION

    Industry-trained AI valuation engine

    Our AI combines biotech expertise with real-time market data to provide accurate valuations based on your unique metrics, development stage, and market potential.

    Valuation Analysis
    AI-Generated
    $28M - $35M
    Based on 15 biotech-specific metrics↑ 12% vs Industry Average
    Key Drivers:
    Novel Mechanism of Action+15%
    Phase II Progress+25%
    IP Portfolio Strength+18%
    Pipeline Score
    92
    Top 5% in category
    Market Size
    $8.2B
    by 2026
    AI Insights
    Similar companies in your therapeutic area raised an average of $32M in Series A
    Your IP portfolio is stronger than 85% of companies at this stage
    FOR INVESTORS
    DEAL FLOW MANAGEMENT

    AI-powered deal discovery

    Let our AI find and analyze the most promising biotech startups based on your investment thesis.

    Portfolio Match Analysis
    3 New Matches
    NeuraTech Bio
    98% Match
    Phase II CNS Therapeutic
    AI Analysis Complete
    High Growth Potential
    FOR INVESTORS
    INTELLIGENT INSIGHTS

    AI market analysis

    Deep insights into biotech trends, competitive landscape, and investment opportunities.

    THERAPEUTIC AREA ANALYSIS
    Oncology
    $45B Market Size32 Early-Stage Startups
    AI Insights:
    Emerging focus on targeted therapies with 3 promising platforms in development
    SHARED PLATFORM
    INTELLIGENT DATA ROOM

    AI-powered due diligence

    Smart data rooms that analyze your documents in real-time, providing instant insights and automated due diligence reports.

    Document Analysis
    AI processing your latest uploads
    Live Updates
    Q4 2023 Financial Report
    PDF • 12 pages
    Analyzed
    Phase II Trial Results
    XLSX • 8 sheets
    Processing
    AI Insights
    Generated from your documents
    Revenue growth increased 32% QoQ, outperforming sector average
    Clinical trial results show 25% better efficacy than competitors
    SHARED PLATFORM
    SMART MESSAGING

    Intelligent communication

    Context-aware messaging with AI assistance for both founders and investors.

    JD
    Sarah Chen
    BioVentures Capital
    Could you provide more details about the Phase II efficacy data?
    AI Assistant Suggests:
    "I'll prepare a summary of our key Phase II metrics, including our 92% efficacy rate and statistically significant p-value of 0.001..."
    RELATIONSHIP MANAGEMENT
    FULL JOURNEY SUPPORT

    From discovery to long-term partnership

    Facilitate the entire founder-investor relationship lifecycle with intelligent tools for discovery, communication, due diligence, and ongoing collaboration.

    Discovery Phase
    Initial Connection
    BioVentures Capital
    98% Match
    AI-powered matching based on investment thesis and startup profile
    "5 similar deals closed in Q1 2024"
    Active Discussion
    Due Diligence
    Shared Documents24
    Data Room Views15
    Questions Answered32
    "All critical documents reviewed"
    Ongoing Partnership
    Regular Updates
    Monthly Board Updates
    Quarterly Financials
    Milestone Tracking
    "Next board meeting scheduled"
    GET EARLY ACCESS

    Join the future of biotech financing

    Be among the first to experience our AI-powered platform. Limited spots available.